Table III.
Relationship between the positive expression of EZH2 and the clinical characteristics of patients.
| EZH2 positive expression | ||||
|---|---|---|---|---|
| Pathological features | Total no. of cases | No. of cases (%) | χ2-value | P-value |
| Menopause | ||||
| Yes | 64 | 46 (71.88) | 0.142 | >0.05 |
| No | 40 | 26 (65.00) | ||
| Age (years) | ||||
| ≥50 | 80 | 56 (70.00) | 0.473 | >0.05 |
| <50 | 24 | 16 (66.67) | ||
| Histology grade | ||||
| I | 42 | 30 (71.43) | 13.287a | <0.05 |
| II | 30 | 22 (73.33) | ||
| III | 32 | 19 (59.38) | ||
| Depth of infiltration | ||||
| Shallow | 38 | 24 (63.16) | 5.692a | <0.05 |
| Deep | 66 | 47 (71.21) | ||
| Lymph node metastasis | ||||
| No | 58 | 38 (65.52) | 8.472a | <0.05 |
| Yes | 46 | 33 (71.74) | ||
| TNM stage | ||||
| I, II | 42 | 28 (66.67) | 6.489a | <0.05 |
| III, IV | 62 | 45 (72.58) | ||
a
χ2 results indicate that the difference in EZH2 expression for the given variable was statistically significant.